GGrantIndex
← Leaderboards

Robert M Strieter

University Of Michigan At Ann Arbor

$9,675,893
Attributed
$9,960,444
Total exposure
9
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200511
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$16,577,709 · 11

By mechanism

P50$7,165,646 · 6
R01$7,148,208 · 3
P01$1,147,213 · 1
T32$1,116,642 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Angiogenesis

Research focus

AngiogenesisChemokineLaboratory MouseAngiogenesis InhibitorsInterferonsLung InjuryVascular EndotheliumLaboratory RatHistopathologyCxcl12 GeneCxcr4 GeneInterleukin 8TissuesIdiopathic Pulmonary FibrosisBcl2 Gene /ProteinAdult Respiratory Distress SyndromeCytokinePhenotypeGenetically Modified AnimalsGenerationsLigandsEndothelial CellsBiologyKinetics

Grant awards (41)

Fibrocytes in human pulmonary fibrosis$569,102
R01 · FY2011 · HL
CXC Chemokines in Cancer$324,371
R01 · FY2010 · CA · contact PI
Chemokines and Fibrocytes in Acute Lung Injury$359,123
R01 · FY2009 · HL · contact PI
CXC Chemokines in Cancer$324,371
R01 · FY2009 · CA · contact PI
Chemokines and Fibrocytes in Acute Lung Injury$359,123
R01 · FY2008 · HL · contact PI
CXC Chemokines in Cancer$324,371
R01 · FY2008 · CA · contact PI
Chemokines and Fibrocytes in Acute Lung Injury$359,123
R01 · FY2007 · HL · contact PI
CXC Chemokines in Cancer$324,371
R01 · FY2007 · CA · contact PI
CXC Chemokines in Cancer$340,673
R01 · FY2006 · CA · contact PI
Chemokines and Fibrocytes in Acute Lung Injury$274,239
R01 · FY2006 · HL · contact PI
Chemokines and Fibrocytes in Acute Lung Injury$97,503
R01 · FY2006 · HL · contact PI
SCOR in Pathology of Fibrotic Lung Disease$1,430,419
P50 · FY2005 · HL
Chemokines and Fibrocytes in Acute Lung Injury$385,000
R01 · FY2005 · HL
Pulmonary and Critical Care Medicine Training Program$375,441
T32 · FY2005 · HL
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$66,642
R01 · FY2005 · CA
SCOR in Pathology of Fibrotic Lung Disease$1,397,507
P50 · FY2004 · HL
Pulmonary and Critical Care Medicine Training Program$367,821
T32 · FY2004 · HL
ANGIOGENESIS IN ACUTE LUNG INJURY$343,125
R01 · FY2004 · HL
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$330,161
R01 · FY2004 · CA
SCOR in Pathology of Fibrotic Lung Disease$1,365,556
P50 · FY2003 · HL
Pulmonary and Critical Care Medicine Training Program$373,380
T32 · FY2003 · HL
ANGIOGENESIS IN ACUTE LUNG INJURY$343,125
R01 · FY2003 · HL
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$330,161
R01 · FY2003 · CA
SCOR in Pathology of Fibrotic Lung Disease$1,276,570
P50 · FY2002 · HL
ANGIOGENESIS IN ACUTE LUNG INJURY$343,782
R01 · FY2002 · HL
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$330,161
R01 · FY2002 · CA
CXC CHEMOKINES REGULATE ANGIOGENESIS IN ARDS$282,412
P50 · FY2002 · HL
Chemokine regulation of angiogenesis in lung cancer$0
P50 · FY2002 · CA
Developmental research program$0
P50 · FY2002 · CA
SCOR in Pathology of Fibrotic Lung Disease$1,147,213
P01 · FY2001 · HL
ANGIOGENESIS IN ACUTE LUNG INJURY$344,250
R01 · FY2001 · HL
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$331,181
R01 · FY2001 · CA
CXC CHEMOKINES REGULATE ANGIOGENESIS IN ARDS$282,412
P50 · FY2001 · HL
CORE--TISSUE$208,827
P50 · FY2001 · HL
CXC CHEMOKINES IN PULMONARY FIBROSIS$208,827
P50 · FY2001 · HL
Developmental research program$0
P50 · FY2001 · CA
Chemokine regulation of angiogenesis in lung cancer$0
P50 · FY2001 · CA
CXC CHEMOKINE REGULATION OF ANGIOGENESIS IN CANCER$344,250
R01 · FY2000 · CA
CORE--TISSUE$255,534
P50 · FY2000 · HL
CXC CHEMOKINES IN PULMONARY FIBROSIS$255,534
P50 · FY2000 · HL
CXC CHEMOKINES REGULATE ANGIOGENESIS IN ARDS$202,048
P50 · FY2000 · HL